News Archive

December 11, 2023 Press

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg Read more

December 07, 2023 Press

BIO Deutschland Yearbook 2023/2024

BIO Deutschland Yearbook 2023/2024 Read more

November 28, 2023 Press

Standardizing tissue quality: Your key to accurate early discovery insights

Standardizing tissue quality: Your key to accurate early discovery insights Read more

September 21, 2023 Press

Precision therapeutics: optimizing early discovery

Precision therapeutics: optimizing early discovery Read more

July 28, 2023 Press

Where the medicine of the future is already being lived in the present

Where the medicine of the future is already being lived in the present Read more

July 24, 2023 Press

Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach

Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach Read more

June 06, 2023 Press

Optimizing early discovery within precision therapeutics

Optimizing early discovery within precision therapeutics Read more

April 04, 2023 Press

Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology

Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology Read more

January 25, 2023 Press

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank Read more

December 23, 2022 Press

Ending the year - Today. Tomorrow. Together.

Ending the year - Today. Tomorrow. Together. Read more

September 07, 2022 Press

Indivumed and CELLphenomics Announce Partnership

Indivumed and CELLphenomics Announce Partnership Read more

April 28, 2022 Press

Indivumed Expands Its Certified Provider Portfolio

Indivumed Expands Its Certified Provider Portfolio Read more

April 05, 2022 Press

Indivumed Celebrates 20th Anniversary

Indivumed Celebrates 20th Anniversary Read more

January 17, 2022 Press

Indivumed receives EU funding from ERDF structural fund

Indivumed receives EU funding from ERDF structural fund Read more

December 12, 2021 Press

Indivumed appoints Dr. Stephan Schüller as CFO

Indivumed appoints Dr. Stephan Schüller as CFO Read more

November 16, 2021 Press

Northwell and Indivumed reach biobank milestone

Northwell and Indivumed reach biobank milestone Read more

October 26, 2021 Press

Indivumed and Biognosys Extend Strategic Partnership

Indivumed and Biognosys Extend Strategic Partnership Read more

August 10, 2021 Press

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs Read more

June 09, 2021 Press

Indivumed becomes Certified Service Provider of the Spatial Transcriptomics technology by 10x Genomics

Indivumed becomes Certified Service Provider of the Spatial Transcriptomics technology by 10x Genomics Read more

June 02, 2021 Press

Indivumed Launches nRavel™ AI Platform

Indivumed Launches nRavel™ AI Platform Read more

May 17, 2021 Press

Indivumed Joins KHR Biotec

Indivumed Joins KHR Biotec Read more

May 06, 2021 Press

Indivumed Expands Digital Pathology Asset and Analysis Capacity

Indivumed Expands Digital Pathology Asset and Analysis Capacity Read more

March 18, 2021 Press

Indivumed Announces Expansion Into Drug Development, Formation of Ix Therapeutics

Indivumed Announces Expansion Into Drug Development, Formation of Ix Therapeutics Read more

January 26, 2021 Press

Indivumed appoints Roald Forsberg as new Chief Business Officer

Indivumed appoints Roald Forsberg as new Chief Business Officer Read more

January 05, 2021 Press

A retrospective and outlook

A retrospective and outlook Read more

November 18, 2020 Press

Indivumed and Ultivue announce collaborative partnership

Indivumed and Ultivue announce collaborative partnership Read more

November 10, 2020 Press

Indivumed Launches Groundbreaking AI Platform to Leverage Multi-omics Data for Discoveries in Oncology

Indivumed Launches Groundbreaking AI Platform to Leverage Multi-omics Data for Discoveries in Oncology Read more

September 03, 2020 Press

Indivumed Announces Global Expansion of Clinical Network to Grow IndivuType Database

Indivumed Announces Global Expansion of Clinical Network to Grow IndivuType Database Read more

August 27, 2020 Press

Indivumed, Gnosis Expand Partnership to Enhance AI and Machine Learning Capabilities

Indivumed, Gnosis Expand Partnership to Enhance AI and Machine Learning Capabilities Read more

August 26, 2020 Press

Statement from Dr. Eric L. Powell, Senior Director, Oncology Research Unit, Pfizer, on the collaboration with Indivumed

Statement from Dr. Eric L. Powell, Senior Director, Oncology Research Unit, Pfizer, on the collaboration with Indivumed Read more

July 14, 2020 Press

First joint webinar of Evotec and Indivumed demonstrates the power of Indivumed’s multi-omics database IndivuType for drug development

First joint webinar of Evotec and Indivumed demonstrates the power of Indivumed’s multi-omics database IndivuType for drug development Read more

May 18, 2020 Press

Indivumed Global Alliance to Broaden Access to Multi-Omics Algorithms

Indivumed Global Alliance to Broaden Access to Multi-Omics Algorithms Read more

April 21, 2020 Press

Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities

Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities Read more

April 15, 2020 Press

Indivumed Launches Global Oncology Alliance For Individualized Medicine ("Onco AI-Med")

Indivumed Launches Global Oncology Alliance For Individualized Medicine ("Onco AI-Med") Read more

April 09, 2020 Press

Indivumed fights COVID-19

Indivumed fights COVID-19 Read more

March 23, 2020 Press

Statement COVID-19 Virus – Information to our customers

Statement COVID-19 Virus – Information to our customers Read more

February 06, 2020 Press

Indivumed Biobank plays a meaningful role in the ICGC/TCGA Pan-Cancer Project to Decipher the Cancer Genome

Indivumed Biobank plays a meaningful role in the ICGC/TCGA Pan-Cancer Project to Decipher the Cancer Genome Read more

January 23, 2020 Press

EVOTEC AND INDIVUMED ANNOUNCE SECOND JOINT DRUG DISCOVERY PROGRAMME

EVOTEC AND INDIVUMED ANNOUNCE SECOND JOINT DRUG DISCOVERY PROGRAMME Read more

January 14, 2020 Press

Indivumed Announces Expansion of the IndivuType Global Cancer Database in Italy

Indivumed Announces Expansion of the IndivuType Global Cancer Database in Italy Read more

December 02, 2019 Press

Indivumed Announces Strategic Partnership with Biognosys

Indivumed Announces Strategic Partnership with Biognosys Read more

October 23, 2019 Press

Indivumed is pleased to announce that we are joining the 25th Bio-Europe

Indivumed is pleased to announce that we are joining the 25th Bio-Europe Read more

September 30, 2019 Press

Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration

Evotec and Indivumed achieve milestone in joint strategic drug discovery collaboration Read more

May 31, 2019 Press

Indivumed launches first real multi-omics cancer platform to advance precision oncology

Indivumed launches first real multi-omics cancer platform to advance precision oncology Read more

May 20, 2019 Press

Indivumed and Gnosis Partner to Add Artificial Intelligence Capabilities to Indivumed´s Platform for multi-omics Cancer Research

Indivumed and Gnosis Partner to Add Artificial Intelligence Capabilities to Indivumed´s Platform for multi-omics Cancer Research Read more

April 26, 2019 Press

Ingress-health and Indivumed announce an international partnership on real-world evidence studies in oncology

Ingress-health and Indivumed announce an international partnership on real-world evidence studies in oncology Read more

April 11, 2019 Press

Evotec and Indivumed announce strategic drug discovery collaboration on precision medicine for colorectal cancer

Evotec and Indivumed announce strategic drug discovery collaboration on precision medicine for colorectal cancer Read more

March 28, 2019 Press

Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services

Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services Read more

March 08, 2019 Press

Indivumed to attend the AACR Annual Meeting, USA, March 31–April 3,2019

Indivumed to attend the AACR Annual Meeting, USA, March 31–April 3,2019 Read more

January 21, 2019 Press

Next In Personalized Medicine: Cancer-Phenotyping

Next In Personalized Medicine: Cancer-Phenotyping Read more

December 18, 2018 Press

Indivumed Announces an International Partnership with IMCB to Establish an Asian-Centric Multiomics Cancer Database for Personalized Oncology

Indivumed Announces an International Partnership with IMCB to Establish an Asian-Centric Multiomics Cancer Database for Personalized Oncology Read more

November 05, 2018 Press

Indivumed opens US-Headquarter in Frederick, MD

Indivumed opens US-Headquarter in Frederick, MD Read more

October 24, 2018 Press

Indivumed to Exhibit at the 30th EORTC-NCI-AACR SYMPOSIUM ,Dublin, November 13–16

Indivumed to Exhibit at the 30th EORTC-NCI-AACR SYMPOSIUM ,Dublin, November 13–16 Read more

July 25, 2018 Press

Indivumed Launches New Biospecimen Product Lines

Indivumed Launches New Biospecimen Product Lines Read more

July 25, 2018 Press

Indivumed Officially Launches Premium Grade Longitudinal Cell-Free Plasma Biospecimens

Indivumed Officially Launches Premium Grade Longitudinal Cell-Free Plasma Biospecimens Read more

July 03, 2018 Press

Indivumed signs agreement with IMCB to build the first global, multiomics cancer database

Indivumed signs agreement with IMCB to build the first global, multiomics cancer database Read more

April 27, 2018 Press

Indivumed to Exhibit at the 3rd Annual Advances in Immuno-Oncology Congress, London, May 24-25

Indivumed to Exhibit at the 3rd Annual Advances in Immuno-Oncology Congress, London, May 24-25 Read more

March 27, 2018 Press

Indivumed Receives Innovation Award at EIB Venture Debt Summit

Indivumed Receives Innovation Award at EIB Venture Debt Summit Read more

February 21, 2018 Press

Indivumed to Exhibit at the AACR Annual Meeting, USA, April 14–18

Indivumed to Exhibit at the AACR Annual Meeting, USA, April 14–18 Read more

January 16, 2018 Press

The Salk Institute and Indivumed Partner to Advance Global Cancer Research

The Salk Institute and Indivumed Partner to Advance Global Cancer Research Read more

January 09, 2018 Press

Investment Plan for Europe: EIB grants loan of EUR 40m to Indivumed

Investment Plan for Europe: EIB grants loan of EUR 40m to Indivumed Read more

November 28, 2017 Press

All-RAS Oncobeam Test von der BARMER erstattet

All-RAS Oncobeam Test von der BARMER erstattet Read more

November 23, 2017 Press

The Importance of Tissue Quality for Personalized Medicine

The Importance of Tissue Quality for Personalized Medicine Read more

November 15, 2017 Press

Indivumed to Exhibit at Molecular Med Tri-Con in San Francisco, USA, February 11–16

Indivumed to Exhibit at Molecular Med Tri-Con in San Francisco, USA, February 11–16 Read more

November 15, 2017 Press

Dual IHC and Quantitative Image Analysis Evaluating Immune Tumor Microenvironments

Dual IHC and Quantitative Image Analysis Evaluating Immune Tumor Microenvironments Read more

October 11, 2017 Press

Indivumed will exhibit at the SITC Annual Meeting in National Harbor, USA, November 8–12

Indivumed will exhibit at the SITC Annual Meeting in National Harbor, USA, November 8–12 Read more

September 19, 2017 Press

Indivumed and Helomics partner to unlock the power of cancer biospecimens for drug discovery and development

Indivumed and Helomics partner to unlock the power of cancer biospecimens for drug discovery and development Read more

August 16, 2017 Press

Indivumed Launches Fluorescent Multiplex IHC

Indivumed Launches Fluorescent Multiplex IHC Read more

August 02, 2017 Press

MedStar Health Collaborates with Indivumed to Advance Precision Oncology Research

MedStar Health Collaborates with Indivumed to Advance Precision Oncology Research Read more

June 02, 2017 Press

Indivumed will have a booth at the T5 JobMesse (job fair) on 11 October, 2017, in Hamburg.

Indivumed will have a booth at the T5 JobMesse (job fair) on 11 October, 2017, in Hamburg. Read more

June 01, 2017 Press

Indivumed and Intermed to form strategic alliance

Indivumed and Intermed to form strategic alliance Read more

May 10, 2017 Press

Indivumed will be participating in the ASCO annual meeting, June 2–6.

Indivumed will be participating in the ASCO annual meeting, June 2–6. Read more

April 11, 2017 Press

Mayor Olaf Scholz honors Hamburg as international medical research location

Mayor Olaf Scholz honors Hamburg as international medical research location Read more

April 10, 2017 Press

Indivumed Founder and CEO recognized for contribution to liquid biopsy innovation

Indivumed Founder and CEO recognized for contribution to liquid biopsy innovation Read more

February 22, 2017 Press

Industry leaders partner for first Indian national cancer database and biobank

Industry leaders partner for first Indian national cancer database and biobank Read more

January 31, 2017 Press

Indivumed to provide Regeneron with tissue samples for Oncology R&D

Indivumed to provide Regeneron with tissue samples for Oncology R&D Read more

January 17, 2017 Press

Northwell Health partners with Indivumed to create cancer research biobank

Northwell Health partners with Indivumed to create cancer research biobank Read more

January 10, 2017 Press

Indivumed joins Blood Profiling Atlas in Cancer (Blood PAC)

Indivumed joins Blood Profiling Atlas in Cancer (Blood PAC) Read more

August 11, 2016 Press

The Pacific Northwest Research Institute and Indivumed GmbH announce strategic collaboration

The Pacific Northwest Research Institute and Indivumed GmbH announce strategic collaboration Read more

July 21, 2016 Press

Indivumed and Definiens partner to utilize tumor tissue for drug discovery and development

Indivumed and Definiens partner to utilize tumor tissue for drug discovery and development Read more

March 08, 2016 Press

Bialystok Medical University continues internationalization with Indivumed partnership

Bialystok Medical University continues internationalization with Indivumed partnership Read more

February 04, 2016 Press

URMC Partners with Indivumed to create tissue bank for cancer research

URMC Partners with Indivumed to create tissue bank for cancer research Read more

Back to News and Publications